NIAID Banner Logo Image

Other Viruses Citation List: May 11 - May 24, 2012

Hepatitis C Virus

1. MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4A Protease with Broad Activity across Genotypes and Resistant Variants. Summa, V., S.W. Ludmerer, J.A. McCauley, C. Fandozzi, C. Burlein, G. Claudio, P.J. Coleman, J.M. Dimuzio, M. Ferrara, M. Di Filippo, A.T. Gates, D.J. Graham, S. Harper, D.J. Hazuda, C. McHale, E. Monteagudo, V. Pucci, M. Rowley, M.T. Rudd, A. Soriano, M.W. Stahlhut, J.P. Vacca, D.B. Olsen, N.J. Liverton, and S.S. Carroll, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22615282].
[PubMed]. OV_0511-052412.

2. Inhibition of Hepatitis C Virus Replication by Intracellular Delivery of Multiple siRNAs by Nanosomes. Chandra, P.K., A.K. Kundu, S. Hazari, S. Chandra, L. Bao, T. Ooms, G.F. Morris, T. Wu, T.K. Mandal, and S. Dash, Molecular Therapy: The Journal of the American Society of Gene Therapy, 2012. [Epub ahead of print]; PMID[22617108].
[PubMed]. OV_0511-052412.

3. Preclinical Characterization of JTK-853, a Novel Non-nucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase. Ando, I., T. Adachi, N. Ogura, Y. Toyonaga, K. Sugimoto, H. Abe, M. Kamada, and T. Noguchi, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22615294].
[PubMed]. OV_0511-052412.

4. The Cyclophilin Inhibitor SCY-635 Disrupts HCV NS5A-Cyclophilin A Complexes. Hopkins, S., M. Bobardt, U. Chatterji, J.A. Garcia-Rivera, P. Lim, and P.A. Gallay, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22585215].
[PubMed]. OV_0511-052412.

5. Discovery of Substituted N-Phenylbenzenesulphonamides as a Novel Class of Non-Nucleoside Hepatitis C Virus Polymerase Inhibitors. May, M.M., D. Brohm, A. Harrenga, T. Marquardt, B. Riedl, J. Kreuter, H. Zimmermann, H. Ruebsamen-Schaeff, and A. Urban, Antiviral Research, 2012. [Epub ahead of print]; PMID[22580131].
[PubMed]. OV_0511-052412.

6. Synthesis and Characterization of 2'-C-Me Branched C-nucleosides as HCV Polymerase Inhibitors. Cho, A., L. Zhang, J. Xu, D. Babusis, T. Butler, R. Lee, O.L. Saunders, T. Wang, J. Parrish, J. Perry, J.Y. Feng, A.S. Ray, and C.U. Kim, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22578461].
[PubMed]. OV_0511-052412.

HSV-1

7. Synthesis and Antiviral Evaluation of C5-Substituted-(1,3-diyne)-2'-deoxyuridines. Sari, O., V. Roy, J. Balzarini, R. Snoeck, G. Andrei, and L.A. Agrofoglio, European Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22578783].
[PubMed]. OV_0511-052412.

8. Cytotoxic, Virucidal, and Antiviral Activity of South American Plant and Algae Extracts. Faral-Tello, P., S. Mirazo, C. Dutra, A. Perez, L. Geis-Asteggiante, S. Frabasile, E. Koncke, D. Davyt, L. Cavallaro, H. Heinzen, and J. Arbiza, The Scientific World Journal, 2012. 2012: p. 174837; PMID[22619617].
[PubMed]. OV_0511-052412.

9. Antiviral Activities and Putative Identification of Compounds in Microbial Extracts from the Hawaiian Coastal Waters. Tong, J., H. Trapido-Rosenthal, J. Wang, Y. Wang, Q.X. Li, and Y. Lu, Marine Drugs, 2012. 10(3): p. 521-538; PMID[22611351].
[PubMed]. OV_0511-052412.

10. In Vitro Antiviral Activity of Dehydroepiandrosterone, 17 Synthetic Analogs and ERK Modulators against Herpes Simplex Virus Type 1. Torres, N.I., V. Castilla, A.C. Bruttomesso, J. Eiras, L.R. Galagovsky, and M.B. Wachsman, Antiviral Research, 2012. [Epub ahead of print]; PMID[22584352].
[PubMed]. OV_0511-052412.

11. Inhibition of Herpes Simplex Virus Infection by Oligomeric Stilbenoids through ROS Generation. Chen, X., H. Qiao, T. Liu, Z. Yang, L. Xu, Y. Xu, H.M. Ge, R.X. Tan, and E. Li, Antiviral Research, 2012. [Epub ahead of print]; PMID[22584350].
[PubMed]. OV_0511-052412.

12. In Vitro and in Vivo Evaluation of a Novel Antiherpetic Flavonoid, 4'-Phenylflavone, and Its Synergistic Actions with Acyclovir. Hayashi, K., M. Iinuma, K. Sasaki, and T. Hayashi, Archives of Virology, 2012. [Epub ahead of print]; PMID[22580497].
[PubMed]. OV_0511-052412.

Citations from the ISI Web of Knowledge Listings for O.V.

13. Novel Peptide Mimetics Based on N-protected Amino Acids Derived from Isomannide as Potential Inhibitors of NS3 Serine Protease of Hepatitis C Virus. Barros, T.G., B.C. Zorzanelli, S. Pinheiro, M.A. de Brito, A. Tanuri, E.C.B. da Costa, R.S. Mohana-Borges, C.R. Rodrigues, A.T.M. Souza, V.F. Ferreira, and E.M.F. Muri, Letters in Organic Chemistry, 2012. 9(4): p. 239-249; ISI[000303256700002].
[WOS]. OV_0511-052412.

12. Antiviral Activity and Resistance Profile of the Novel HCV NS5A Inhibitor GS-5885. Cheng, G., B. Peng, A. Corsa, M. Yu, M. Nash, Y.J. Lee, Y. Xu, T. Kirschberg, Y. Tian, J. Taylor, J.O. Link, and W. Delaney, Journal of Hepatology, 2012. 56: p. S464-S464; ISI[000303241302279].
[WOS]. OV_0511-052412.

13. Synthesis and Antiviral Activity of a Series of 1 '-Substituted 4-aza-7,9-dideazaadenosine C-Nucleosides. Cho, A., O.L. Saunders, T. Butler, L.J. Zhang, J. Xu, J.E. Vela, J.Y. Feng, A.S. Ray, and C.U. Kim, Bioorganic & Medicinal Chemistry Letters, 2012. 22(8): p. 2705-2707; ISI[000302768200010].
[WOS]. OV_0511-052412.

14. Identification and Characterization of PPI-383, a Next Generation HCV NS5B Non-Nucleoside Inhibitor with Potent Activity against all Major HCV Genotypes. Colonno, R., N. Huang, M. Lau, Q. Huang, A. Huq, E. Peng, M. Bencsik, M. Zhong, and L. Li, Journal of Hepatology, 2012. 56: p. S464-S464; ISI[000303241302280].
[WOS]. OV_0511-052412.

15. Minimal-Length shRNAs are Potent Inhibitors of Hepatitis C Virus in HCV-Infected Chimeric Mice. Dallas, A., H. Ma, H. Ilves, J. Shorenstein, M. Behlke, S.P. Wong, R. Harbottle, I. Maclachlan, S. Kazakov, S. Sankuratri, K. Klumpp, and B.H. Johnston, Journal of Hepatology, 2012. 56: p. S25-S25; ISI[000303241300058].
[WOS]. OV_0511-052412.

16. Raloxifene Hydrochloride as a Novel Antiviral Agent: Inhibition of Hepatitis C Virus (HCV) Replication. Furusyo, N., E. Ogawa, M. Sudoh, M. Murata, T. Ihara, H. Ikezaki, T. Hayashi, S. Hiramine, and J. Hayashi, Journal of Hepatology, 2012. 56: p. S438-S438; ISI[000303241302219].
[WOS]. OV_0511-052412.

17. Direct Binding of a Hepatitis C Virus Inhibitor to the Viral Capsid Protein. Kota, S., V. Takahashi, F. Ni, J.K. Snyder, and A.D. Strosberg, Plos One, 2012. 7(2); ISI[000302999600026].
[WOS]. OV_0511-052412.

18. Inhibition of Hepatitis C Virus Infectivity by Anti-viral Drugs in Human HCV Infected Liver Slices Culture. Lagaye, S., P. Halfon, H. Shen, J. Gaston, L. Hannoun, P.P. Massault, A. Vallet-Pichard, V. Mallet, and S. Pol, Journal of Hepatology, 2012. 56: p. S332-S332; ISI[000303241301410].
[WOS]. OV_0511-052412.

19. The Lectin Griffithsin has Antiviral Activity Against Hepatitis C Virus in Vitro and in Vivo. Meuleman, P., A. Albecka, S. Belouzard, K. Vercauteren, L. Verhoye, C. Wychowski, G. Leroux-Roels, K.E. Palmer, and J. Dubuisson, Journal of Hepatology, 2012. 56: p. S335-S336; ISI[000303241301420].
[WOS]. OV_0511-052412.

20. Discovery of 4 '-Azido-2 '-deoxy-2 '-C-methyl Cytidine and Prodrugs Thereof: A Potent Inhibitor of Hepatitis C Virus Replication. Nilsson, M., G. Kalayanov, A. Winqvist, P. Pinho, C. Sund, X.X. Zhou, H. Wahling, A.K. Belfrage, M. Pelcman, T. Agback, K. Benckestock, K. Wikstrom, M. Boothee, A. Lindqvist, C. Rydegard, T.H.M. Jonckers, K. Vandyck, P. Raboisson, T.I. Lin, S. Lachau-Durand, H. de Kock, D.B. Smith, J.A. Martin, K. Klumpp, K. Simmen, L. Vrang, Y. Terelius, B. Samuelsson, A. Rosenquist, and N.G. Johansson, Bioorganic & Medicinal Chemistry Letters, 2012. 22(9): p. 3265-3268; ISI[000302964300045].
[WOS]. OV_0511-052412.

21. Antiviral Activity of EP-NI266, a Potent Nucleotide HCV Polymerase Inhibitor. Owens, C.M., M.H.J. Rhodin, A. Polemeropoulos, I.J. Kim, Y.L. Qiu, G. Wang, L.J. Jiang, and Y.S. Or, Journal of Hepatology, 2012. 56: p. S475-S476; ISI[000303241302307].
[WOS]. OV_0511-052412.

22. In Vitro Combinatory Effect of HCV NS3/4A Protease Inhibitor ABT-450, NS5A Inhibitor ABT-267, and Non-Nucleoside NS5B Polymerase Inhibitor ABT-333.Pilot-Matias, T., G. Koev, P. Krishnan, J. Beyer, T. Reisch, R. Mondal, L. Lu, T. Middleton, C. Maring, W. Kati, C. Collins, and A. Molla, Journal of Hepatology, 2012. 56: p. S338-S338; ISI[000303241301426].
[WOS]. OV_0511-052412.

23. Anti-hepatitis C Virus Activity of 3-Hydroxy Caruilignan C from Swietenia macrophylla Stems. Wu, S.F., C.K. Lin, Y.S. Chuang, F.R. Chang, C.K. Tseng, Y.C. Wu, and J.C. Lee, Journal of Viral Hepatitis, 2012. 19(5): p. 364-370; ISI[000302800600009].
[WOS]. OV_0511-052412.

24. Inhibition of Hepatitis C Virus Replication and Viral Helicase by Ethyl Acetate Extract of the Marine Feather Star Alloeocomatella polycladia. Yamashita, A., K.A. Salam, A. Furuta, Y. Matsuda, O. Fujita, H. Tani, Y. Fujita, Y. Fujimoto, M. Ikeda, N. Kato, N. Sakamoto, S. Maekawa, N. Enomoto, M. Nakakoshi, M. Tsubuki, Y. Sekiguchi, S. Tsuneda, N. Akimitsu, N. Noda, J. Tanaka, and K. Moriishi, Marine Drugs, 2012. 10(4): p. 744-761; ISI[000303261000005].
[WOS]. OV_0511-052412.

25. Preclinical Characteristics of ACH-3102: A Novel HCV NS5A Inhibitor with Improved Potency against Genotype-1A Virus and Variants Resistant to 1st Generation of NS5A Inhibitors. Yang, G., J. Wiles, D. Patel, Y. Zhao, J. Fabrycki, S. Weinheimer, C. Marlor, J. Rivera, Q. Wang, V. Gadhachanda, A. Hashimoto, D. Chen, G. Pais, X. Wang, M. Deshpande, K. Stauber, M. Huang, and A. Phadke, Journal of Hepatology, 2012. 56: p. S330-S330; ISI[000303241301404].
[WOS]. OV_0511-052412.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2022